Expression of Cyclooxygenase (COX)-2 as a Prognostic Factor in Nasopharyngeal Cancer
1
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
PURPOSE: To evaluate the relationship between treatment failure and COX-2 expression in nasopharyngeal cancer patients treated with chemotherapy and radiotherapy. MATERIALS AND METHODS: The subjects of this study were 22 nasopharyngeal cancer patients. The patients were treated with neoadjuvant chemotherapy, followed by radiotherapy, or with radiotherapy alone. The formalin- fixed, paraffin- embedded tissues of 11 patients who developed a locoregional recurrence (n=7) or distant metastasis (n=4) were compared with those of 11 disease free patients. Prognostic factors, including histological type, stage, radiation dose and chemotherapy, were well balanced between the two groups. The COX-2 expression was determined immunohistochemically. RESULTS: COX-2 expression was stronger in the patients with a locoregional recurrence or distant metastasis than in those free of disease. The COX-2 distribution scores of the control group were as follows: 0 in 7, 1 in 2 and 2 in 2 patients. In the recurrence group, the scores were as follows; 0 in 3, 1 in 1, 2 in 2 and 3 in 5 patients. COX-2 expression was shown to have a statistically significant influence on the treatment failure by the Mann-Whitney U test (p=0.024) and Mantel-Haenszel Chi-Square test (p=0.018). It also significantly influenced the treatment failure when an analysis was performed within patients with a undifferentiated histology (p=0.039 by the Mann- Whitney U test, p=0.037 by the Mantel-Haenszel Chi- Square test). CONCLUSION: COX-2 expression is believed to be one of the important factors associated with a locoregional recurrence or distant metastasis.(Cancer Res Treat. 2004;36:187-191)
참고문헌 (24)
- "Preliminaryresults of a randomized trial comparing neoadjuvant chemotherapy(cisplatin, epirubicin, bleomycin) plus radiotherapy vs.radiotherapy alone in stage IV undifferentiated nasopharyngealcarcinoma: A positive effect on progression-free survival", 35, pp.463~469 (1996)
- "Chemoradiotherapy versus radiotherapy in patients withadvanced nasopharyngeal cancer: Phase III randomized intergroupstudy 0099", 16, pp.1310~1317 (1998)
- "Prognostic significance of cyclooxygenase-2 pathwayand angiogenesis in head and neck squamous cell carcinoma", 33, pp.708~714 (2002)
- "Cyclooxygenase-2:A novel molecular target for the preventionand treatment of head and neck cancer", 24, pp.792~799 (2002)
- "Cyclooxygenase-2 expression is up-regulatedin squamous cell carcinoma of head and neck", 59, pp.991~994 (1999)
- "Expression ofcyclooxygenase-2 in human breast carcinoma:relevance totumor angiogenesis and expression of estrogen receptor", 33, pp.286~295 (2001)
- "Expression of cyclooxygenase-2 protein in gastric carcinogenesis", 34, pp.252~257 (2002)
- "Expressionof cyclooxygenase-2 and tumor microvessel density incolorectal cancer", 35, pp.400~406 (2003)
- "Cyclooxygenase-2 overexpressionis a marker of poor prognosis in stage I non-small cell lungcancer", 7, pp.861~867 (2001)
- "Up-regulation of cyclooxygenase-2 in squamouscarcinogenesis of the esophagus", 6, pp.1229~1238 (2000)
- "Increased expression ofcyclooxygenase-2 protein in human gastric cancer", 6, pp.519~525 (2000)
- "The relationshipbetween cyclooxygenase-2 expression and colorectal cancer", 282, pp.1254~1257 (1999)
- "High cyclooxygenase-2expression is related with distant metastasis in cervical cancertreated with radiotherapy", 55, pp.16~20 (2003)
- "Aspirin and the risk of colorectalcancer in women", 333, pp.609~614 (1995)
- "Aspirin and reduced risk of esophagealcarcinoma", 76, pp.1116~1119 (1995)
- "Modulation of ratmammary carcinogenesis by indomethacin", 45l, pp.1803~1808 (1985)
- "Treatment of colonic and rectal adenomas with sulindac infamilial adenomatous polyposis", 328, pp.1313~1316 (1993)
- "Increased cyclooxygenase 2(COX-2)expression occurs frequently in precursor lesions of humanadenocarcinoma of the lung", 30, pp.73~81 (2000)
- "Selective inhibition of cyclooxygenase-2 suppresses growth andinduces apoptosis in human esophageal adenocarcinoma cells", 60, pp.5767~5772 (2000)
- "Suppressionof Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibitionof Cyclooxygenase 2(COX-2)", 87, pp.803~809 (1996)
- "COX-2 expression in dysplasia of the head andneck:Correlation with elF4E", 92, pp.1888~1895 (2001)
- "A selective cyclooxygenease-2 inhibitor,NS-398,enhances the effect of radiation in vitro and in vivo preferentiallyon the cells that express cyclooxygenase-2", 7, pp.2998~3005 (2001)
- "Preferential enhancement oftumor radioresponse by a cyclooxygenase-2 inhibitor", 60, pp.1326~1331 (2000)
- "Increased cyclooxygenase-2 expression inhuman squamous cell carcinomas of the head and neck andinhibition of proliferation by nonsteroidal anti-inflammatorydrugs", 22, pp.2089~2096 (2002)